Skip to main content

Table 1 Confirmation of CNV benchmark sets by three orthogonal methods (based on regions, Mb)

From: Evaluation of somatic copy number variation detection by NGS technologies and bioinformatics tools on a hyper-diploid cancer genome

Confidence level

Collapsed calls from NGS

Affymetrix Cytoscan

Illumina array

Bionano

Validated by at least one technology

Validated by at least two technologies

Copy number gain

 Strong

1542.1

858.2

883.3

1243.8

1357.2  (88.0%)

1099.5  (72.3%)

 Medium

35.0

3.1

0.3

11.7

14.6  (41.8%)

0.5  (1.3%)

 Weak

69.1

0.1

0.1

12.9

13.0  (18.8%)

0.1  (0.1%)

 Neutral

992.3

0.7

0.3

17.3

18.1  (1.8%)

0.2  (0.0%)

Copy number loss

 Strong

79.7

79.7 

79.5

78.9

79.7  (100%)

79.6  (99.9%)

 Medium

1.1

1.1

0.5

0.3

1.1  (94.9%)

0.5  (44.1%)

 Weak

24.2

23.3

7.6

7.7

23.3  (96.1%)

7.7  (31.8%)

 Neutral

1518.9

799.8

23.5

24.4

800.7  (52.7%)

24.5  (1.6%)